Viking Global Investors Lp
Affiliations
- at 4D Molecular Therapeutics Inc. (FDMT), 2023-05-11
- at Frazier Lifesciences Acquisition Corp (FLAC), 2022-11-25
- at Rallybio Corp (RLYB), 2022-11-17
- at Inhibrx Inc. (INBX), 2022-10-12
- at Amylyx Pharmaceuticals Inc. (AMLX), 2022-09-10
- at Procept Biorobotics Corp (PRCT), 2022-03-23
- at Ginkgo Bioworks Holdings Inc. (DNA), 2022-03-05
- Large Shareholder at Api Group Corp (API), 2022-01-06
- at Roivant Sciences Ltd. (ROIV), 2021-10-01
- Large Shareholder at Figs Inc. (FIGS), 2021-09-03
- Large Shareholder at Adaptive Biotechnologies Corp (ADPT), 2020-12-17
- Large Shareholder at Zentalis Pharmaceuticals Inc. (ZNTL), 2020-12-03
- Other at Arbutus Biopharma Corp (ABUS), 2019-07-13
- Other at Axovant Gene Therapies Ltd. (AXON), 2019-07-13
- Other at Myovant Sciences Ltd. (MYOV), 2019-07-13
- Other at Urovant Sciences Ltd. (UROV), 2019-07-13
- Large Shareholder at Bridgebio Pharma Inc. (BBIO), 2019-06-28
- Large Shareholder at First Data Corp (FDC), 2016-04-15
- Other at Editas Medicine Inc. (EDIT), 2016-02-09
- Large Shareholder at Wayfair Inc. (W), 2014-11-24
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| FDMT | $16.00 | 850,000 | 4,787,914 | 2023-05-09 | Filing | ||
| FLAC | $10.08 | 279,530 | 1,211,582 | 2022-11-02 | Filing | ||
| FLAC | $10.08 | 567,532 | 2,459,880 | 2022-11-02 | Filing | ||
| INBX | $30.00 | 333,333 | 333,333 | 2022-10-07 | Filing | ||
| INBX | $30.00 | 1,000,000 | 2,427,307 | 2022-10-07 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| AMLX | $31.44 | 3,142 | 1,850,940 | 2022-09-09 | Filing | ||
| AMLX | $30.90 | 73,886 | 1,854,082 | 2022-09-09 | Filing | ||
| AMLX | $29.87 | 147,502 | 1,927,968 | 2022-09-09 | Filing | ||
| AMLX | $31.44 | 6,654 | 3,919,596 | 2022-09-09 | Filing | ||
| AMLX | $30.90 | 156,463 | 3,926,250 | 2022-09-09 | Filing |